Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests

v3.20.1
Non-Controlling Interests
3 Months Ended
Mar. 31, 2020
Non-Controlling Interests  
Non-Controlling Interests

12. Non-Controlling Interests

Non-controlling interests in consolidated entities are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

For the three months ended

    

    

 

    

    

 

 

 

As of March 31, 2020

 

March 31, 2020

 

 

As of March 31, 2020

 

 

 

 

 

 

 

 

Net loss attributable to

 

non-controlling interests

 

Non-controlling

 

($ in thousands)

    

NCI equity share

 

Non-controlling interests

 

in consolidated entities

 

ownership

 

Aevitas

 

$

(1,989)

 

$

(186)

 

$

(2,175)

 

35.8

%

Avenue 2

 

 

5,419

 

 

(955)

 

 

4,464

 

77.3

%

Baergic

 

 

(1,201)

 

 

(3)

 

 

(1,204)

 

33.0

%

Cellvation

 

 

(917)

 

 

(38)

 

 

(955)

 

20.6

%

Checkpoint  1

 

 

15,121

 

 

(2,403)

 

 

12,718

 

78.4

%

Coronado SO

 

 

(290)

 

 

-

 

 

(290)

 

13.0

%

Cyprium

 

 

(795)

 

 

(89)

 

 

(884)

 

18.9

%

Helocyte

 

 

(4,700)

 

 

(165)

 

 

(4,865)

 

18.8

%

JMC

 

 

118

 

 

159

 

 

277

 

6.9

%

Mustang 2

 

 

39,640

 

 

(8,008)

 

 

31,632

 

69.0

%

Tamid

 

 

(651)

 

 

(10)

 

 

(661)

 

22.8

%

Total

 

$

49,755

 

$

(11,698)

 

$

38,057

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

For the twelve months ended

 

    

 

 

    

 

 

 

As of December 31, 2019

 

 

December 31, 2019

 

 

As of December 31, 2019

 

 

 

 

 

 

 

Net loss attributable to 

 

non-controlling interests 

 

Non-controlling 

 

($ in thousands)

    

NCI equity share

    

Non-controlling interests

    

 in consolidated entities

    

 ownership

 

Aevitas

 

$

(1,249)

 

$

(694)

 

$

(1,943)

 

35.8

%

Avenue 2

 

 

24,269

 

 

(19,011)

 

 

5,258

 

77.3

%

Baergic

 

 

23

 

 

(1,162)

 

 

(1,139)

 

33.0

%

Cellvation

 

 

(732)

 

 

(158)

 

 

(890)

 

20.6

%

Checkpoint 1

 

 

29,389

 

 

(14,687)

 

 

14,702

 

78.0

%

Coronado SO

 

 

(290)

 

 

-

 

 

(290)

 

13.0

%

Cyprium

 

 

(320)

 

 

(99)

 

 

(419)

 

10.6

%

Helocyte

 

 

(4,322)

 

 

(402)

 

 

(4,724)

 

19.3

%

JMC

 

 

(211)

 

 

325

 

 

114

 

6.9

%

Mustang 2

 

 

62,025

 

 

(25,727)

 

 

36,298

 

70.3

%

Tamid

 

 

(565)

 

 

(85)

 

 

(650)

 

22.8

%

Total

 

$

108,017

 

$

(61,700)

 

$

46,317

 

 

 

 

Note 1: Checkpoint is consolidated with Fortress’ operations because Fortress maintains voting control through its ownership of Checkpoint’s Class A Common Shares which provide super-majority voting rights.

Note 2: Avenue and Mustang are consolidated with Fortress’ operations because Fortress maintains voting control through its ownership of Preferred Class A Shares which provide super-majority voting rights.